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ABSTRACT
Using CHO cells we sought to explore and characterize the functional relationship
of rainbow trout MC5 receptor (rtMC5R) with zebrafish MRAP1 (zfMRAP1) and
rainbow trout MC2 receptor (rtMC2R), as well as how the effect of such relationships
may play a significant role in Hypothalamic-Pituitary-Adrenal/Interrenal axis activation.
This research demonstrated that rtMC5R can be successfully expressed and functionally
activated in CHO cells and, in a manner similar to mammals, α-MSH is the preferred
ligand for rtMC5R. The presence of MRAP1 does not seem to inhibit the expression or
function of rtMC5R, rather it appears that it may increase expression and total activation
levels. In contrast, the presence of MRAP1 in conjunction with MC2R reduces
expression and total activation levels of rtMC5R. Findings indicate that rtMC5R may
function in three different ways in a cell, depending upon the presence of other local
proteins. The interaction of rtMC5R with MRAP1 and MC2R, and the implications of
such interactions will be described in this thesis.
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INTRODUCTION
The Melanocortin System
The melanocortin system is composed of melanocortin receptors, their accessory
proteins, and their ligands. Melanocortin receptors (MCRs) are a family of small G
protein-coupled receptors (GPCRs) (Gantz and Fong, 2003). MCRs are in subclass A-13
of the class-A, rhodopsin-like, GPCR family (Hinkle and Sebag, 2009). Like all GPCRs
MCRs have 7 membrane spanning domains, and are coupled to an intracellular G-protein
(Hinkle and Sebag, 2009). These receptors preferentially bind protein hormones derived
from pro-opiomelanocortin (POMC). POMC is selectively processed to produce the
melanocortins as well as β-endorpin and β-lipotropin (Eipper and Mains, 1980). The
protein hormones known as melanocortins include the family of melanocyte stimulating
hormones, α-MSH, β-MSH and γ-MSH as well as adrenocorticotropic hormone (ACTH).
The MCRs bind the melanocortins with varying levels of selectivity, as seen in table 1.
Activation of MCRs results in a similar cascade of events to other GPCRs. Upon
ligand binding, the α-subunit of the G-protein is released which activates adenylyl
cyclase. Adenylyl cyclase activation results in the production of the second messenger
cyclic AMP (cAMP). Intracellular levels of cAMP regulate protein kinase A (PKA), and
in our studies an increase in cAMP allows us to measure activity levels of our receptors
(Chan et al., 2011).
1

Table 1 Localization, physiological function and ligand preference of melanocortin
receptors 1 through 5 in mammals. Adapted from Cone, 2006
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Five MCRs are expressed in the mammalian system, and are numbered by the
order in which they were discovered. MCRs are expressed in differing patterns
throughout the body, and each displays different physiological functions. Pigmentation is
a main role of the melanocortin 1 receptor (MC1R), which is localized in cutaneous
melanocytes, though it is also found in immune cells, keratinocytes, endothelial cells,
fibroblasts, pituitary and testis (Gantz and Fong, 2003; Chhanjali, 1996). MC1R binds all
POMC derivatives, showing equal preference for α-MSH, β-MSH and ACTH over γMSH (Cooray and Clark, 2011).
Responding to circulating ACTH as a result of corticotropin releasing hormone
(CRH) release from the hypothalamus, MC2R is involved in the chronic stress response
(Chan et al., 2011). MC2R is also called the ACTH receptor, because it is the lone
receptor that binds only ACTH (Gantz and Fong, 2003). MC2R is found in adrenal cells,
as well as adipocytes, brain tissue, testis and the spleen (Chhanjali, 1996). The MC2R is
involved in steroidogenesis, including synthesis of cortisol, corticosterone and
aldosterone, and is also involved in the stress response as part of the HypothalamicPituitary-Adrenal axis (HPA) (Figure 1) (Chan et al., 2011).
Melanocortin 3 is localized in the brain, stomach, pancreas, heart, kidneys,
skeletal muscle, intestine, plancenta, testis and ovaries (Cone, 2006; Chhanjali, 1996). A
major physiological role of MC3R is in energy homeostasis as well as inflammatory
action (Cooray and Clark 2011). This receptor is unique due to the fact that it lacks a
preference for any specific POMC derivative, and binds all melanocortins with near equal
affinity (Cone, 2006).
3

Figure 1 The Hypothalamic-Pituitary-Adrenal Axis. Activation begins in the cerebral
cortex, which triggers release of corticotropin-releasing hormone (CRH) from the
hypothalamus. CRH stimulates the anterior pituitary to release ACTH, which then binds
MC2R in the adrenal cortex. Stimulation of the adrenal cortex by ACTH results in
cortisol release.
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MC4R is predominantly localized in the nervous system, and binds α-MSH,
ACTH and β-MSH with equal affinity (Cooray and Clark, 2011). This receptor is
involved in sexual function and appetite regulation, as well as energy homeostasis similar
to MC3R (Cooray and Clark, 2011).
The most recent MCR to be identified was MC5R, and knowledge of function and
localization of this receptor is quickly growing. Possibly the most widely distributed
MCR, MC5R is involved in exocrine function and therefore expressed in a variety of
exocrine glands, including lacrimal, preputial and Harderian glands, as well as
adipocytes, the adrenal gland, kidneys, testis, ovary, pituitary, and parts of the immune
system (Cone, 2006; Gantz and Fong, 2003; Chhanjali, 1996). Results regarding the
ligand preference of MC5R have been contradictory; some data supporting a preference
for α-MSH over ACTH and vice versa. MC5R can also bind the rest of the
melanocortins as well (Cone, 2006).

Activation of Mammalian MCRs
In mammals MC1R, MC3R, MC4R, and MC5R can bind and be activated to
varying degrees by either ACTH or the MSHs (Gantz and Fong, 2005). In contrast,
MC2R can only be activated by ACTH (Cooray and Clark, 2011). Expression and ligand
preference studies for the MCRs were first performed in heterologous mammalian cell
lines such as HEK293 cells, COS cells, HeLa cells and CHO cells. Though MC1R,
MC3R, MC4R and MC5R were expressed, activated and characterized with little
difficulty, performing the same task with MC2R was not so easily accomplished.
5

Scientists were eventually able to express MC2R in cell lines derived from the adrenal
gland, it was not until 2005 that the melanocortin-2 receptor accessory protein (MRAP)
was identified as being the protein critical for MC2R expression (Metherell et al., 2005).

History and Knowledge of the MRAP System
To date there have been identified two accessory proteins that are part of this
system, melanocortin receptor accessory proteins 1 and 2 (MRAP1 and 2, respectively).
MRAPs are type 1 proteins with a single membrane spanning domain. These accessory
proteins can both control the expression of MCRs on the plasma membrane, as well as
assist in protein folding and trafficking (Sebag and Hinkle, 2008). MRAPs have been
shown to immunoprecipitate with all five MCRs; however, MC2R requires MRAP in
order to be functional, while MC1R, MC3R, MC4R and MC5R functionality is reduced
by MRAP (Chan et. al, 2009). MRAPs have been found to form single pass, antiparallel
homo- and heterodimers in which both termini protrude from the extracellular and
intracellular face of the plasma membrane (Hinkle and Sebag, 2010).
In the human melanocortin system MRAP1 is required for the functional
expression of MC2R (Figure 2A). MRAP involvement in activation of MC2R by ACTH
is critical, and just a few point mutations in the MRAP sequence can result in MC2R
being unable to be activated by ACTH, as shown by Sebag and Hinkle (2008). MRAP1
mutants with alanine substitutions were tested, and it was found that substitutions for
residues other than 18-21 allowed for normal interaction with, and activation of MC2R.
When alanines were substituted for residues 18-21, MC2R was still trafficked to the
6

plasma membrane; however the receptor could not be activated by ACTH. These studies
indicated residues 18LDYI21 play a critical role in MRAP1 function. In addition, removal
of residues 31-37 resulted in MRAP1 no longer forming antiparallel homodimers, and
MC2R trafficking and dimerization were blocked (Sebag and Hinkle, 2008).
The two MRAP orthologs share significant homology, however, due to a few
differences in amino acid sequence, the two proteins do not share identical function
(Sebag and Hinkle 2008). Similar to MRAP1, MRAP2 is capable of trafficking MC2R to
the plasma membrane. However, MRAP2 is incapable of enabling activation of MC2R
once it reaches the plasma membrane. In their 2008 paper, Sebag and Hinkle showed
that insertion of the LDYI motif into MRAP2 was enough to allow MC2R to be activated
in the presence of MRAP2 only.
The requirement of MRAP for functional expression of MC2R is unique in the
melanocortin family, though the interaction of MRAP with MC2R is not. As stated,
MRAPs have been found to interact with all MCRs to differing degrees, with different
results. Most notably for our experiments, when MC5R is expressed in the presence of
MRAP it is no longer able to traffic to the plasma membrane (Figure 2B). Further studies
showed a disruption in the formation of MC5R homodimers when MRAP was present
(Sebag and Hinkle 2009).
MRAPs, MC2R and MC5R are all found in adrenal cortex cells, as well as the
head kidney in fishes, and the inverse MCR/MRAP relationships provide cells with a
well preserved mechanism by which to regulate receptor expression.

7

Figure 2 A) A schematic of the functional interaction between MRAP and MC2R. In
the absence of MRAP, MC2R remains in the ER and is not trafficked to the plasma
membrane. When MRAP is present, it forms an antiparallel homodimer which then
interacts with MC2R and both are trafficked to the plasma membrane and MC2R can be
activated with MRAP1. B) A schematic of the functional interaction between MRAP and
MC5R. Alone MC5R is capable of being trafficked to the plasma membrane and being
activated. The presence of MRAP prevents MC5R from being trafficked to the plasma
membrane. Adapted from Clark, 2011
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Teleosts MCR System
Teleost fish have a melanocortin system similar to mammals, with 5 subtypes of
MCRs, and 2 MRAP orthologs, however there are some differences. Unlike mammals,
teleost fishes do not have adrenal glands. Instead there is a head kidney which is a
localization of adrenocortical cells in the most anterior portion of the kidney (Aluru and
Vijayan, 2008). The head kidney acts in a manner similar to adrenal glands in mammals,
responding to ACTH and releasing corticosteroids (Aluru and Vijayan, 2008). Another
difference teleosts possess in contrast to mammals is a variance in the number of MCRs
each species possess. Takifugu rubripes has a single copy of MCRs 1, 2, 4 and 5 and are
missing a copy of MC3R (Västermark and Schiöth, 2011). Zebrafish on the other hand
have six MCRs, possessing a single copy of receptors 1-4 and two copies of MC5R
(Västermark and Schiöth, 2011). To date only the standard five MCRs have been
identified in rainbow trout.
In rainbow trout MC5R has been found in the head kidney as well as the brain and
ovary (Haitina et al., 2004). In addition, MC2R is expressed in the head kidney of
rainbow trout (Aluru and Vijayan, 2008). At the time of this thesis research, a rainbow
trout MRAP ortholog had not been identified, though MRAP1 had been localized to the
head kidney in zebrafish (Agulleiro et al., 2010). Rainbow trout MC2R (rtMC2R)
exhibits the same need for MRAP1 as observed in mammals, and zebrafish MRAP1 is
sufficient to allow normal trafficking and function of the rtMC2R (Liang et al., 2011).
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The Hypothalamic-Pituitary-Adrenal Axis
The HPA is involved in a complex cascade of events known as the stress
response, as well as many other actions. Activation of the HPA begins with the
glucocorticoid sensing neurons located in the hippocampus. A drop in cortisol detected
by these neurons will lead to the release of the polypeptide CRH from neurons in the
hypothalamus. CRH will travel via the median eminence to the anterior pituitary where
corticotropic cells will be stimulated to release ACTH. This polypeptide hormone travels
via the circulatory system to the adrenal cortex, binds to the MC2 receptor, and the result
is the release of cortisol. Due to the lack of adrenal glands in teleosts, the HPA is instead
referred to as the Hypothalamic-Pituitary-Interrenal axis (HPI; Norris, 2006).

Ligand Production
All ligands of melanocortin system originate from a single precursor protein
known as pro-opiomelanocortin (POMC). POMC is produced and processed in many
cells of the body, including the pituitary gland. Prohormone convertases 1/3 and 2
(PC1/3 and PC2) in the anterior and intermediate lobes of the pituitary gland,
respectively, are responsible for the bulk of the processing of POMC to produce the
melanocortins. Upon signaling from the hypothalamus these enzymes selectively cleave
POMC to produce ACTH in the corticotroph cells of the anterior lobe of the pituitary,
and α-MSH, β-MSH, and γ-MSH in melanotroph cells of the intermediate lobe of the
pituitary (Figure 3).
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Figure 3 Selective processing of POMC by enzymes PC1/3, and PC2. Some KR
cleavage sites are suspected to be selected by PC2, but have not been confirmed.
Abbreviations: CPE = carboxypeptidase E, K = lysine, R = arginine. Figure from
Helwig et al., 2006
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Experimental Question
In an effort to determine how far back the functional relationship between MC5R,
MC2R and MRAP1 goes evolutionarily, we set out to determine ligand selectivity and
functional activity of the rtMC5R and the relationship between MC5R, MRAP1 and
MC2R in rainbow trout. More specifically we sought to answer whether rtMC5R is
activated by either ACTH or α-MSH; is there a preference? In addition, is the functional
expression of rtMC5R is influenced by the presence of MRAP1, rtMC2R or a
combination? In rainbow trout α-MSH release is involved in coloration changes. Our
experiment will address how such a release could potentially affect head kidney
stimulation. Thus addressing the question, is it possible that the α-MSH release activates
MC5R in the head kidney and results in release of cortisol and activation of the stress
response? Or does a MC5R/MRAP relationship exist similar to that found in mammals,
resulting in a lack of MC5R expression in the head kidney?

Hypotheses and Experimental Design
Previous characterization of the MC5R, MRAP, MC2R relationships in mammals
led us to hypothesize that rtMC5R can be functionally expressed on the plasma
membrane on its own, but the addition of either rtMC2R or zfMRAP1 may inhibit
trafficking and expression of MC5R. In addition we hypothesize that such a relationship
is necessary to prevent activation of the HPI axis during coloration change events.
The present study uses immunofluorescence and cell surface ELISA to show
plasma membrane expression of rtMC5R in CHO cells. Furthermore, the relationship
12

between rtMC5R, zfMRAP1, and rtMC2R is characterized through cyclic AMP
functional assays in addition to immunoprecipitation and western blotting.
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METHODS AND MATERIALS
Tissue Culture
The Chinese hamster ovary cell line (CHO), purchased from the American Type
Culture Collection (ATCC, Manassas, VA, USA), was used for all experiments
performed. Cells were maintained in F12K medium, supplemented with 10% heat
inactivated fetal bovine serum (FBS), 100U/mL Penicillin and 100mg/mL streptomycin
(Invitrogen, Carlsbad, CA, USA) and 100µg/mL Normocin™ (InvivoGen, San Diego,
CA, USA). Cells were grown at 37ºC in 5%CO2-95% air with a relative humidity of 7090%. Media was changed 3 times weekly. At 70-80% confluence cells were subcultured
using the following protocol. Medium was aspirated, cells rinsed in 1X phosphate
buffered saline (PBS) and detached with trypsin EDTA 1X (Mediatecch, Manassas, VA,
USA) for 3 minutes at 37ºC. Media was added to inactivate trypsin. Subcultures were
obtained by placing a small aliquot of trypsinized cells in a new flask with fresh media.

Immunofluorescence and Lipofection
Transient transfections of the CHO cell line were achieved using lipofectamine
2000 (Invitrogen, Carlsbad, CA) and Opti-MEM (Cellgro, Manassas, VA) with standard
protocol, and 1.5µg each cDNA or GFP vector.
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Tranfections were performed using cDNA for rainbow trout MC5R (sequenced by
Haitina et al. 2004) with a HA epitope tag at the N-terminal, rainbow trout MC2R
(accession no. 100136719) with a V-5 epitope tag at the N-terminal, and zebrafish
MRAP1 (accession no. 100007319) or mouse MRAP1 (accession no. NP_084120.1) with
a FLAG epitope tag at the N-terminal; all synthesized by GenScript (Piscataway, NJ).
Construct combinations are listed below. Transfected cells were cultured on 8 chamber
slides with 2.5 x 106 cells per well. At 24 hours post-transfection, cells were fixed with
4% paraformaldehyde in 1X PBS (PFA) 15 minutes, then permeablized with 0.3%
Triton-X in 1X PBS for 10 minutes. Cells were incubated for 1 hour at 37ºC with
monoclonal mouse anti-HA, monoclonal mouse anti-V-5 or polyclonal rabbit anti-V-5,
and polyclonal rabbit anti-FLAG primary antibodies (1:500 in 1X PBS). Slides were
rinsed in triplicate with 1X PBS, then incubated for 45 minutes with secondary antibody
(1:800 in 1X PBS) at 37°C. Donkey anti-mouse antibody linked to Alexa-Fluor488, and
donkey anti-rabbit antibody linked to Alexa-Fluor555 were used. Cover slips were
mounted onto slides using Vectashield (Vector Lab, Burlingame, CA), and nuclei were
stained with DAPI. Images were viewed under oil immersion at 100X on the Axioplan-2
fluorescense microscope (Zeiss, Ostalbkreis, Baden-Württemberg, Germany) using the
slidebook imaging software (www.slidebook.com).
Experimental combinations were as follows: rtMC5R; rtMC5R and rtMC2R; rtMC5R
and mMRAP1; rtMC5R, rtMC2R and zfMRAP1. Controls were performed as follows:
non-transfected cells were treated with primary and secondary antibodies; or transfected
were treated with secondary antibody.
15

Nucleofection and Cyclic AMP Reporter Assay
Transient transfections of the CHO cell line were achieved via nucleofection
using the Nucleofector® II Device (Lonza, Walkersville, MD, USA). Cells were
transfected using program U-023, solution T (Lonza), ≤ 3.0 x 106 cells per reaction and
2µg of each cDNA construct. Cells were allowed to recover for 10 minutes at 37ºC in
500µL media, and plated. Media was changed 24 hours post transfection.
Transient transfections of the CHO cell line were performed using MC5R, MC2R
and MRAP1 constructs in conjunction with a Cre-LUC reporter gene (compliments of
Dr. Patricia Hinkle, Rochester, NY) in combinations as listed below. 2.5x106 cells were
used per reaction, and cells were plated at a density of 105 cells per well in 96-well plates.
Forty-eight hours post transfection media was removed and cells were stimulated for 4
hours with NDP α-MSH or ACTH(1-24) (Sigma-Aldrich, St. Louis, MO) at
concentrations ranging from 10-12 to 10-6 in serum-free CHO media. Stimulation
solutions were then removed and 100 μl of Bright-Glo luciferase assay reagent (Promega
Inc., Madison, WI) was applied to each well. Following a 5 minute incubation at room
temperature, luminescence was measured using Bio-Tek Synergy HT plate reader
(Winooski, VT). Experiments were performed in triplicate, and data were analyzed with
Kaleidograph software using Student’s t-test for equal variance. Significance was set at
p<0.05.
Experimental combinations were as follows: rtMC5R; rtMC5R and rtMC2R;
rtMC5R and zfMRAP1; rtMC5R, rtMC2R and zfMRAP1; rtMC2R; rtMC2R and
zfMRAP1. All combinations were cotransfected with a Cre-LUC reporter gene.
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Cell Surface ELISA
Cells were transiently transfected using lipofection as previously described (Liang
et al., 2011), with different combinations of rtMC5R, rtMC2R and zfMRAP1 cDNA
constructs. Transfected cells were cultured on 24-well plates with 5X105 cells per well.
24 hours post lipofection media was aspirated and cells were washed once with 1X PBS.
Cells were then fixed with 200µL 4% PFA and half the wells were permeablized with
200µL 0.3% Triton-X. Blocking buffer (5% non-fat dry milk in 1X PBS, supplemented
with 10% FBS and 5% normal goat serum; 190µL/well) was added, and plates were
incubated at 4ºC overnight. Primary antibody against HA or V-5 at 1:2000 dilution was
added 48 hours post lipofection, and allowed to incubate for 2 hours at room temperature.
Wells were washed in triplicate with 1X PBS followed by a 45 minute incubation with
secondary goat anti-mouse antibody conjugated with HRP (1:2000 dilution at room
temperature). Wells were again washed in triplicate, and allowed to dry before adding
200 µL TMB (Tetramethyl Benzidine; Invitrogen, Frederick, MD) and allowed to
incubate for 10 minutes at room temperature. The reaction was halted by adding 200 µL
1N HCl and gently swirling. 300 µL from each well was transferred to a 96-well plate
and immediately read at absorption 450nm by Bio-Tek Synergy HT plate reader. All
experiments were performed in triplicate with a GFP transfected control. Data were
normalized to GFP control and analyzed using Student’s t-test for equal variance with
Kaleidograph software. Significance was determined using Student’s t-test for equal
variance at p<0.05.
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Experimental combinations were as follows: rtMC5R; rtMC5R and rtMC2R; rtMC5R
and zfMRAP1; rtMC5R, rtMC2R and zfMRAP1; rtMC2R; rtMC2R and zfMRAP1.

Immunoprecipitation
Transient transfections of the CHO cell line were achieved through nucleofection
as described above (see Methods). Cells were detached using trypsin 48 hours post
transfection, centrifuged at 5000 rpm for 10 minutes, and then media was removed. Cells
were resuspended in 1X sterile PBS and spun at 2000 rpm for 10 minutes. Cells were
lysed in 0.1% n-dodecyl-β-maltoside (Thermo, Rockford, IL) in 1X TBS, 1mM EDTA
and 1% Triton, pH8, placed on ice for 15 minutes then spun at 10,000 rpm for 20
minutes. Supernatant was removed and tumbled overnight at 4°C with primary antibody
against HA, using 1:1000 dilution. Magnetic protein A/G beads (Thermo) were added
and lysate tumbled for 1 hour at 4°C. Pellet was washed twice in lysis buffer, then
solubilized in 50µL western blot sample buffer and run. This procedure was provided by
Dr. Patricia Hinkle (Rochester, NY).

Western Blot
Transient transfections of the CHO cell line were performed as previously
described. Cells were detached with trypsin, spun at 5000 rpm for 10 minutes,
resuspended in 1X sterile PBS and spun again at 2000 rpm for 10 minutes. Cells were
lysed using 25-100µL NuPAGE LDS sample buffer (Invitrogen, Carlsbad, CA), placed
on ice and sonicated briefly until no longer viscous. Lysate was divided into 25µL
18

aliquots and used or stored at -20°C. NuPAGE reducing buffer DTT (Invitrogen) was
mixed with sample buffer LDS, 250µL and 584.5µL, respectively, and 8µL of mixture
was added to 25µL of lysate. Lysate mixture was then boiled for 10 minutes. Boiled
lysate mixture (10µL) or immunoprecipitations were run on NuPAGE 3-8% Tris-acetate
(Life Technologies, Carlsbad, CA) gel in NuPAGE MES SDS running buffer (Invitrogen,
Carlsbad, CA), diluted 20:1, loading every third well with a blank. Gels were run at
20mA constant current for 10-20 minutes followed 50mA constant current for the
remainder. HiMark™ pre-stained high molecular weight protein standard (Life
Technologies) and MagicMark™ XP Western Protein Standard were used. Blots were
carried out in TGS buffer 1:10 (Bio-Rad, Hercules, CA), using a semi-dry preparation
and run at 300mA constant current. Blots were rock incubated overnight at 4°C in
primary antibody against HA, V-5 and FLAG 1:1000 in blotto with 0.5M sodium azide.
The following morning, blots were rinsed and rocked in 1X TBST, three times for five
minutes each. Alexa conjugated secondary antibodies were used at 1:1000 dilution in
blotto + azide and incubated for 45 minutes, followed again by three washes in 1X TBST.
Western blots were read using BioRad Molecular Imager FX and Quantity One®
software (Bio-Rad).
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RESULTS
Immunofluorescence
To determine if rtMC5R could be successfully transfected in CHO cells, cells
were transfected with the rtMC5R construct and immunofluorescence staining was
performed on permeablized cells (Figure 4A). Positive staining for MC5R was observed
throughout the cell, demonstrating successful transfection and expression of rtMC5R in
the CHO cell line. In addition, unpermeablized cells were stained (Figure 4B) and
positive staining was observed on the plasma membrane, appearing as a green perimeter
around the cell. Observation of a prominently stained perimeter in unpermeablized cells
confirmed proper trafficking and localization of rtMC5R to the plasma membrane in
CHO cells. Controls of untransfected CHO cells with immunofluorescence staining, and
rtMC5R transfected CHO cells subjected only to secondary antibody were performed; no
sign of non-specific or background staining was observed (Figures 4C and 4D).
To test for interactions between rtMC5R, rtMC2R and MRAP, CHO cells were
transfected with different combinations of cDNA constructs, and immunofluorescence
staining was carried out on unpermeablized cells. Due to difficulties with zfMRAP1
staining, a mouse MRAP1 construct was used in some cases. Cotransfection of rtMC5R
with mMRAP1 showed signs of colocalization of the two proteins. Prominent, intense
staining was observed for both rtMC5R (Figure 5A) and mMRAP (Figure 5B) along the
20

Figure 4 Immunofluorescence Staining of CHO cells A) A permeablized CHO cell
transfected with rtMC5R (green). Receptor can be visualized throughout the cell. B)
Unpermeablized CHO cells transfected with rtMC5R (green). Cells have an intense,
green perimeter indicative of rtMC5R localization to the plasma membrane. C)
Untransfected CHO cells with immunofluorescence staining using primary antibody
against HA, V-5 and FLAG tag, and Alexa-conjugated secondary antibody. No nonspecific staining can be seen. D) CHO cells transfected with rtMC5R were only
incubated with Alexa-conjugated secondary antibody; no primary antibodies were used.
There is no sign of non-specific staining. All cell nuclei were stained with DAPI (blue).
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Figure 5 Images A-C are of CHO cells (unpermeablized) cotransfected with rtMC5R
(green) and mMRAP1 (red). A) Intense staining shows rtMC5R on the plasma
membrane. B) mMRAP appears localized on the plasma membrane. C) Overlay of A
and B shows what appears to be colocalization of rtMC5R with mMRAP, indicative of a
possible protein interaction. Images D-F are of unpermeablized CHO cells cotransfected
with rtMC5R (green) and rtMC2R (red). Arrows indicate areas of strongest staining on
the plasma membrane. D) Intense staining is less apparent than in (B), indicating a
possible reduction in rtMC5R on the plasma membrane. E) Staining for rtMC2R with a
small amount of slightly intense staining on areas of the plasma membrane. F) An
overlay of images D and E shows a small amount of possible colocalization. All nuclei
were stained with DAPI (blue).
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cell perimeter. An overlay of the two images gave a strong indication of colocalization
and a possible interaction between the two proteins (Figure 5C).
In cells cotransfected with rtMC5R and rtMC2R it appeared that rtMC5R was not
being trafficked to the plasma membrane as efficiently. This is evidenced by the lack of
intense staining for rtMC5R along most of the cell perimeter (Figure 5D). In addition,
rtMC2R lacked intense staining along most of the cell perimeter (Figure 5E). An overlay
of images showed evidence of possible colocalization of the two receptors on the plasma
membrane (Figure 5F).
Finally, CHO cells were transfected with cDNA for all three peptides, and stained
for rtMC5R with rtMC2R, or rtMC5R with zfMRAP1. When all three peptides were
expressed in the cell, rtMC5R still appeared to localize to the plasma membrane, and
staining with HA antibodies resulted in intense staining on the plasma membrane (Figure
6A). Staining for rtMC2R however, was not as prominent as for rtMC5R (Figure 6B).
An overlay of images A and B showed slight evidence for colocalization of the two
receptors, though still a large amount of rtMC5R did not appear to be colocalized with
rtMC2R (Figure 6C). Triple transfection and staining for rtMC5R with zfMRAP1
showed strong evidence for colocalization. Rainbow trout MC5R shows prominent
staining on the plasma membrane in figure 6D, as does zfMRAP1 in figure 6E. An
overlay of the two images shows a large amount of colocalization, and suggests a
possible interaction between the two proteins (Figure 6F). Simultaneous staining of
rtMC5R, rtMC2R and zfMRAP1 was not performed.
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Figure 6 Images A-C are of CHO cells (unpermeablized) cotransfected with rtMC5R
(green), rtMC2R (red) and zfMRAP1. A) Intense staining shows rtMC5R on the plasma
membrane. B) Staining shows rtMC2R on the plasma membrane, though not as
intensely as rtMC5R. C) Overlay of A and B shows what appears to be a small amount
of colocalization of rtMC5R with rtMC2R, indicative of a possible protein interaction.
Images D-F are of unpermeablized CHO cells cotransfected with rtMC5R (green),
zfMRAP1 (red) and rtMC2R. D) Intense staining of rtMC5R is apparent on the plasma
membrane. E) Zebrafish MRAP1 staining on areas of the plasma membrane indicates
localization to the plasma membrane. F) An overlay of images D and E shows what
appears to be a large amount of colocalization of rtMC5R with zfMRAP1. All nuclei
were stained with DAPI (blue).
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Ligand Selectivity of Rainbow Trout MC5 Receptor
Since cAMP is a second messenger produced when MCRs bind ligand, cAMP
measurement was used to determine activation levels of receptors in CHO cells. Due to
conflicting reports of ligand preference of MC5R, the initial assay carried out determined
rtMC5R ligand preference by stimulating cells with both NDP-α-MSH and ACTH(1-24)
(Reinick et al., 2012; Ling et al., 2004)(Figure 7A). The mammalian MC5R shows
varying degrees of preference for α-MSH over ACTH (Gantz and Fong, 2003) so it was
predicted that the rtMC5 receptor would show a similar preference. As expected, cAMP
functional assays performed on CHO cells expressing rtMC5R displayed a significant
preference for NDP-α-MSH (EC50 = 5.0±2.4 x 10-10 M) over ACTH(1-24) (EC50 = 6.3 ±
2.5 x 10-9 M)(p = 0.041) (Figure 7B). Rainbow trout MC5R was cotransfected with
rtMC2R in the initial series of cAMP experiments, and resulted in a slight shift of
activation curves; however the observed shifts were not significant (Figures 7C and 7D).

Functional Relationship Characterization
To continue characterizing the functional relationship between rtMC5R, rtMC2R
and zfMRAP1, CHO cells were cotransfected with differing combinations of constructs
and stimulated with NDP-α-MSH, the preferred ligand for rtMC5R. When expressing
rtMC5R with combinations of zfMRAP1 and rtMC2R, there were differing levels of
rtMC5R functionality (Figure 8A). As seen in the initial cAMP assay, when transfected
alone, rtMC5R can be activated by NDP-α-MSH (EC50 = 3.8 ± 0.08 x 10-10M). When
rtMC5R was co-transfected with zfMRAP1, it was unexpected that activation levels were
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Figure 7 Preferred ligand curves for rtMC5R. A) CHO cells were transfected with
rtMC5R and, cotransfected with rtMC5R and rtMC2R, then stimulated with NDP-αMSH or ACTH 1-24. EC50 values are as follows: rtMC5R + NDP-α-MSH = 5.0 ± 2.4 x
10-10M, rtMC5R + rtMC2R + NDP-α-MSH = 2.3 ± 1.4 x 10-10M, rtMC5R + ACTH(1-24)
= 63 ± 25 x 10-10M, rtMC5R + rtMC2R + ACTH(1-24) = 1.6 ± 0.52 x 10-9M. Figures BD are separate graphs of the same curves as seen in figure A. B) rtMC5R alone shows a
significant preference for NDP-α-MSH over ACTH. p=0.041 C) Comparison of
activation curves for rtMC5R tranfected cells and rtMC5R/rtMC2R cotransfected cells
stimulated with NDP-α-MSH. p=0.206 D) Comparison of activation curves for rtMC5R
tranfected cells, and rtMC5R and rtMC2R cotransfected cells stimulated with ACTH(124). p=0.069
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Figure 8: cAMP activity assay performed on CHO cells transfected with different
combinations of rtMC5R, rtMC2R and zfMRAP and stimulated with NDP-α-MSH. A)
Transfection of CHO cells with rtMC5R results in a standard activation curve (EC50 = 3.8
± 0.8 x 10-10M). The addition of zfMRAP does not significantly change the EC50 (3.0 ±
1.0 x 10-10M) of the activation curve, though the total activation level is higher. Cotransfection of rtMC5R with zfMRAP and rtMC2R results in a significant change in EC50
(0.15 ± 0.08 x 10-10M) p=0.01 B) A decrease in the amount of rtMC5R cDNA
transfected into cells results in similar set of activation curves to (A), however there is no
significant difference between curves.
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not significantly different, with an EC50 value of 3.0 ± 1.0 x 10-10M (p = 0.28). Though
the EC50 value is not significantly different from rtMC5R alone, the combination of
rtMC5R with zfMRAP1 appears to increase rtMC5R total activation levels.
Simultaneous expression of rtMC5R, zfMRAP1 and rtMC2R significantly decreased
MC5R activation by NDP-α-MSH to an EC50 of 1.5 ± 0.8 x 10-11M (p=0.01). Repetition
of this experiment, with a reduced amount of rtMC5R cDNA vector, from 2µg to 0.2µg,
resulted in similar activation curves; however, EC50 values were not significantly
different from each other (Figure 8B).
To further understand and characterize the interactions between rtMC5R,
rtMC2R, and zfMRAP, a similar set of functional assays were performed, but cells were
stimulated with ACTH(1-24) to assess rtMC2R activity (Figure 9). Results were as
expected; when transfected alone, rtMC2R showed no activation. The addition of
zfMRAP1 gave a normal activation curve with an EC50 value of 1.8 ± 1.0 x 10-10M; this
curve served as the basis for comparison for the rest of the MC2R activation curves.
Co-transfection of rtMC2R with rtMC5R resulted in a significant drop in cAMP levels
(EC50 = 3.6 ±1.0 x 10-10M) (p=0.01). Expression of all three peptides lowered the EC50
value (EC50 = 1.0 ± 0.6 x 10-10M), but the decrease in activation was not statistically
significant (p = 0.45).
Two possible scenarios provided a plausible explanation for the significant
decrease in rtMC5R functionality when combined with both rtMC2R and zfMRAP1.
First, the presence of rtMC2R along with zfMRAP causes a conformational change in the
rtMC5R that prevents the receptor from effectively binding its ligand and thus being
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Figure 9 Cyclic AMP activity assays performed on CHO cells transfected with varying
combinations of rtMC2R, rtMC5R and zfMRAP. Cells were stimulated with ACTH(124) to test for rtMC2R activity. Activity of cells cotransfected rtMC2R and zfMRAP1
served as the control in this assay. Cotransfection of all three cDNA constructs resulted
in a significant drop in EC50, though the cotransfection of rtMC2R with rtMC5R did not
result in a significant shift in EC50 from the control. P-values are as follows: between
rtMC2R+zfMRAP1 and rtMC2R+rtMC5R p = 0.01; between rtMC2R+zfMRAP1 and
rtMC2R+zfMRAP1+rtMC5R p=0.45; between rtMC2R+zfMRAP1+rtMC5R and
rtMC2R+rtMC5R p=0.34.
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activated. This explanation was unlikely since the presence of zfMRAP1 alone did not
produce any significant changes in receptor functionality. A second, and more likely
explanation, was that the majority of receptor was not reaching the plasma membrane,
making it impossible to be activated by its ligand, and resulting in the significant
decrease in activation. These two theories were tested by cell surface ELISAs on
transfected CHO cells.

Cell Surface Expression of Rainbow Trout MC Receptors
Cell surface ELISA was performed on CHO cells transfected with the same
combinations of rtMC5R, rtMC2R and zfMRAP1 as performed for cAMP assays. Initial
assays used staining for the HA-epitope tag on rtMC5R (Figure 10). Results supported
the idea that the decreased activation levels observed in cyclic AMP assays were a result
of decreased expression of rtMC5R on the plasma membrane, rather than due a
conformational change in the receptor which results in an inability of the receptor to
functionally bind ligand. Cotransfection of rtMC5R with rtMC2R resulted in reduced
surface expression of rtMC5R, though not significantly (p=0.053). This result coincides
with the decrease in staining seen in the immunofluorescence assay. The combination of
both receptors with zfMRAP1 however, does result in a significant decrease in rtMC5R
cell surface expression (p=0.005). The co-expression of rtMC5R with zfMRAP1 did not
result in a decrease in receptor expression (p=0.75), which coincides with the lack of a
change in activation levels in the cAMP activity assays.
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Figure 10 Cell surface ELISA, with primary staining for HA epitope tag on rtMC5R.
Cotransfection of rtMC5R with rtMC2R decreased the amount of rtMC5R detected on
the plasma membrane, p=0.053. Cotransfection with zfMRAP1 resulted in a slight
increase in detected surface expression of rtMC5R, p=0.75. Cotransfection of all three
cDNA constructs led to a significant decrease in detectable rtMC5R on the cell surface,
p=0.005.

31

Figure 11 Cell surface ELISA, primary staining for V-5 epitope tag. Cotransfection of
rtMC2R with rtMC5R resulted in no significant change in surface expression of rtMC2R,
p=0.074. Cotransfection with zfMRAP1 resulted in an increase in detected surface
expression of rtMC2R, however the increase was not significant, p=0.097.
Cotransfection of all three cDNA constructs led to a significant increase in detectable
rtMC2R on the cell surface, p=0.03.
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When performing the same experiment, but staining for rtMC2R expression
(Figure 11), the only significant change in expression levels observed was that the
combination of rtMC2R, rtMC5R and zfMRAP1 (p=0.03), though the cotransfection of
rtMC2R with zfMRAP1 did increase the surface expression of rtMC2R, (p=0.097). It
should be noted that the difference between expression of all three peptides, and the
expression of just rtMC2R with zfMRAP1 was not significant (p=0.8). It was not
surprising that expression of rtMC2R with rtMC5R did not cause an increase in rtMC2R
surface expression, as it has been established that MC2R cannot be trafficked to the
plasma membrane in the absence of MRAP1. (Metherell et al., 2005)
Decreased surface staining for both HA and V-5 epitope tags when all three
proteins were simultaneously expressed provided strong evidence that the most likely
explanation for the decrease in plasma membrane expression of MCRs was the formation
an oligomer consisting of rtMC5R, rtMC2R and zfMRAP1, which cannot be efficiently
trafficked to the plasma membrane. To test this theory, immunoprecipitation and western
blotting assays were carried out.

Immunoprecipitation of Rainbow Trout MC5 Receptor
Initial immunoprecipitation and western blots were run in order to determine
whether dimers could be expected to run through the gel without dissociating. rtMC5R is
341 amino acids long, so a single protein would be expected to result in bands at either
34kDa or 68kDa if protein had not been glycosylated; glycosylation would result in
larger bands (Haitina et al., 2004). The initial trial showed a large band at approximately
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90kDa, indicating a glycosylated homodimer (Figure 12). Once it was confirmed that
these dimers could stay intact in the gel, immunoprecipitation was carried out on CHO
cells transfected with combinations of receptors and zfMRAP1. A control was employed
in which no primary antibody was used during the immunoprecipitation process with
cells singly transfected with rtMC5R. Faint bands were identified at approximately
90kDa in lanes run with immunoprecipitated rtMC5R transfected cells. Lanes run with
cells that were cotransfected were ultimately inconclusive (Image not shown).
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Figure 12 Western Blot Analysis of rtMC5R expressed in CHO cells. Lanes 2 and 8
were run with immunoprecipitated HA-tagged rtMC5R. A clear band is present in both
lanes at approximately 90kDa, indicative of glycosylated homodimers. Lane 5 was run
with CHO cell lysate from cells singly transfected with rtMC5R; a faint band is apparent
at approximately 90kDa as well. Lane 11 was run with untransfected CHO cell lysate, no
band was apparent. Every third lane was run blank.
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DISCUSSION
The emergence of differential posttranslational processing mechanisms for the
polypeptide hormone precursor, proopiomelanocortin (POMC) (Eipper and Mains, 1980),
has resulted in the evolution of two distinct hypothalamus/pituitary axes: the
hypothalamus/anterior pituitary/adrenal/interrenal axis (HPA/I), and the
hypothalamus/intermediate pituitary/chromatophore/melanocyte axis (HPC/M). The
former axis mediates the production of glucocorticoids by adrenal cortex or interrenal
cells to facilitate the normal daily function of organ systems and to mediate chronic stress
events (Norris, 2006). The later axis mediates either physiological color change
(chromatophores) or the production of pigment granules in the integument (Norris, 2006).
In the HPA/I axis, the critical end-product derived from the posttranslational processing
of POMC is the melanocortin, ACTH (adrenocorticotropin). In the HPC/M axis, the
critical end-products derived from POMC are the melanocortins, α-, β-, and γ- MSH
(melanocyte stimulating hormone) (Figure 1). In addition, the functionality of both axes
has been influenced by co-evolution with the melanocortin receptor gene family. In the
HPA/I axis, adrenal cortex and interrenal cells express the melanocortin-2 receptor
(MC2R), a GPCR that can only be activated by ACTH (Cone, 2006). In the HPC/M axis,
chromatophores and melanocytes express the melanocortin-1 receptor (MC1R), a GPCR
that can be activated by either ACTH or α-MSH with nearly equal efficacy (Gantz and
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Fong, 2003). Hence, during a period of chronic stress, the release of high levels of ACTH
will not only stimulate glucocorticoid synthesis, but also could result in a change in
pigmentation in organisms like the teleost, Oncorhynchus mykiss (the rainbow trout).
However, is the converse true? When a rainbow trout utilizes the HPC/M axis is there a
rise in glucocorticoid release from interrenal cells? The initial response to this question
after the characterization of the MC2 receptor in 1992 (Mountjoy et al., 1992), was no;
the ACTH receptor on adrenal cortex or interrenal cells can only be activated by ACTH,
and not by any of the MSHs. However, with the subsequent identification of five
melanocortin receptors (i.e., MC1R, MC2R, MC3R, MC4R, and MC5R; Cone, 2006), it
has become apparent that target cells may express more than one melanocortin receptor at
a time.
In the case of the HPA/I axis, the mechanism for regulating a response to ACTH
became, on one hand more complex with the realization that the MC2 receptor requires
interaction with the melanocortin-2 accessory protein 1 (MRAP1; Metherell et al., 2005).
Yet this interaction, at least in mammals, provided a mechanism for regulating the
melanocortin receptor trafficking to the plasma membrane. It is now apparent that
mammalian adrenal cortex cells will express MC2R, MC5R, and MRAP1 (Cooray and
Clark, 2011). Previous studies had established that mammalian MC5R can be activated
by ACTH or α-MSH (Gantz and Fong, 2003). However, in vitro analysis of the
interactions between mammalian MC2R, MC5R, and MRAP1 revealed that the MC2R +
MRAP1 interaction ensured proper trafficking of MC2R to the plasma membrane and
facilitated activation of this receptor (Sebag and Hinkle, 2009). Conversely, MC5R
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+MRAP1 interaction led to a decrease in the trafficking of MC5R to the plasma
membrane (Sebag and Hinkle, 2009) and a corresponding decline in the production of
cAMP when MC5R/MRAP1 transfected cells were stimulated with either ACTH(1-24)
or NDP-α-MSH (Beleckis, 2012).
Based on these observations, coupled with the discovery that the interrenal cells
of the rainbow trout also express MC2R, MC5R, and MRAP1 (Haitina et al., 2004;
personal communication Prof. Mathilakath Vijayan, University of Waterloo, Canada).
The present study was conducted to address the hypothesis that the MC2R/MRAP1 and
MC5R/MRAP1 interactions were ancestral features of the melanocortin receptors which
emerged early in the radiation of the ancestral gnathostomes. These ancestral
gnathostomes gave rise to the teleosts (rainbow trout) and the tetrapods (mammals). To
test this hypothesis, three in vitro conditions were analyzed: 1) the expression and ligand
selectivity properties of rainbow trout (rt) MC5R in a heterologous mammalian cell line
(CHO); 2) the expression and ligand selectivity properties of rtMC5R and rtMC2R coexpressed in CHO cells; and 3) the expression and ligand selectivity properties of
rtMC5R, rtMC2R, and zebrafish MRAP1 co-expressed in CHO cells. The first two
analyses can provide a view of the pharmacological properties of the rtMC5 receptor, and
it is highly likely that there are some rtMC5R target cells that either only express the
MC5 receptor, or may express MC5R and MC2R. The third analysis provides an in vitro
reconstruction of receptor and accessory protein conditions in rainbow trout interrenal
cells and may be the most physiologically relevant of the three analysis paradigms. A
summary of these analysis paradigms follows.
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Rainbow Trout MC5R expression in CHO cells: Single receptor expression studies
The following comments summarize the properties of rtMC5R either expressed
alone or in co-expression with zfMRAP1. Immunofluorescence analysis of rtMC5R
expressed in CHO cells revealed that this cDNA construct could be expressed in CHO
cells and the receptor could successfully traffic to the plasma membrane without the
necessity for an accessory protein. Rainbow trout MC5R was clearly visualized both
inside the cell (permeablized cells; Figure 4A) and on the plasma membrane
(unpermeablized cells; Figure 4B). These results are consistent with mammalian MC5R
behavior (Sebag and Hinkle, 2009).
When CHO cells were co-transfected with rtMC5R and zfMRAP1, immuno
analyses indicated the probability of an interaction between rtMC5R and zfMRAP1 as
evidenced by the appearance of co-localization in images taken of cells transfected with
both cDNA constructs (Figure 5C). Interestingly, this potential interaction was observed
in unpermeablized cells, indicating that rtMC5R was still being trafficked to the plasma
membrane in the presence of MRAP1. Further imaging studies, including FRET, could
provide more support for interactive behavior of rtMC5R with MRAP1.
Ligand selectivity studies on cells transfected only with rtMC5R indicated that αMSH is a more potent ligand than ACTH(1-24). These results are in agreement with the
ligand selectivity studies on mammalian MC5Rs (Haitina et al., 2004). Hence, during
activation of the HPC/M axis it is highly likely that target cells expressing rtMC5
receptor are activated.
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In CHO cells transfected with rtMC5R and zfMRAP1, the presence of zfMRAP1
did not interfere with the functional activation of the transfected cells (Figure 8A and
8B). These data coincide with the immunofluorescence observations mentioned above,
which showed rtMC5R on the plasma membrane, co-localized with mMRAP1.
However, when the same analysis was done for CHO cells transfected with hMC5R and
mMRAP1 (Beleckis, 2012), there was a significant drop in cAMP production following
stimulation with either NDP-α-MSH or ACTH(1-24). These observations pointed to a
clear difference between the interaction of rtMC5R/MRAP1 and hMC5R/MRAP1 which
was further clarified by a cell surface ELISA analysis.
Sebag and Henkle (2009) used a cell surface ELISA analysis to show that coexpression of hMC5R and mMRAP1 resulted in a decrease in the expression of hMC5R
on the plasma membrane. In these experiments some hMC5R/mRAP1 complexes appear
to be retained in the ER. When the same paradigm was applied to CHO cells cotransfected with rtMC5R and zfMRAP1, there was no evidence for a decrease in rtMC5R
surface expression (Figure 10). Again, this coincides with the results from
immunofluorescence assays and cAMP reporter assays.
It is also conceivable that rtMC5R interaction with MRAP1 results in decreased
internalization rates of MC5R from the plasma membrane, which in turn increases the
duration of cell surface expression of rtMC5R and also explains the increased overall
activation rates observed in the cAMP reporter assays. Yet another plausible explanation
which was not explored is the possibility that MRAP1 causes a conformational change in
rtMC5R which results in a change of ligand preference, causing MC5R to bind ACTH
40

with higher affinity. Such a phenomenon was suggested by Chan et al., 2004. The latter
hypothesis would be simple to test initially with a cyclic AMP activity assay similar to
the one performed to determine the ligand preference of rtMC5R. Ultimately, this is an
interaction that needs further investigation, preferably through the use of a rainbow trout
MRAP1 ortholog.

Rainbow Trout MC5R expression in CHO cells: co-expression with rtMC2R
The following experiments were done to see if co-expression of rtMC5R and
rtMC2R would alter either the trafficking of rtMC5R to the plasma membrane or affect
the ligand selectivity of rtMC5R. Immunofluorescence analysis was suggestive of colocalization of rtMC5R with MC2R, as seen in Figure 5F. It was surprising that rtMC2R
was trafficked to the plasma membrane in the absence of MRAP, as it has been well
established that MC2R requires MRAP to be trafficked to the plasma membrane
(Metherell et al., 2006). It is possible that the presence of both receptors results in the
formation of a heterodimer which allows MC2R to traffic to the plasma membrane,
though it is likely that rtMC2R is not functional in this situation, as it has been
demonstrated that the necessity of MRAP1 in MC2R function goes beyond initial
trafficking to the plasma membrane (Metherell et al., 2006).
Receptor functionality was also evaluated in CHO cells co-expressing rtMC5R
and rtMC2R, and resulted in only a slight decrease in EC50 values following stimulation
with either NDP-α-MSH (2.3 ± 1.4 x 10-10M) or ACTH(1-24) (1.6 ± 0.52 x 10-9M), as
compared to the same treatment of rtMC5R alone (NDP-α-MSH = 5.0 ± 2.4 x 10-10M;
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ACTH(1-24) = 63 ± 25 x 10-10M) (figures 7C and 7D). These results give the impression
that rtMC2R does not interfere greatly with the functionality of rtMC5R, however the
inverse relationship may be harder to define. When cells co-expressing rtMC2R and
MRAP1 are stimulated with ACTH(1-24) the EC50 value (1.8 ± 1.0 x 10-10M) was
significantly higher than cells co-expressing rtMC5R and rtMC2R (EC50 = 3.6 ±1.0 x 1010

M)(p = 0.01) (Figure 9).
Due to the fact that both rtMC5R and rtMC2R can be functionally activated by

ACTH, the cAMP levels that were measured when cells were transfected with both
receptors and stimulated with ACTH(1-24) cannot be fully attributed to a single receptor
or both receptors with absolute certainty (Figures 7A, 7D and 9). As a result of such
uncertainty, any loss, decrease, or gain of function as a result of an interaction between
the two receptors cannot be identified. The ambiguity of these results could potentially
be alleviated by the use of rtMC5R and rtMC2R homologues that behave normally in all
ways, but cannot be functionally activated. These receptors can be folded, glycosylated
and trafficked to the plasma membrane as a normal, functional receptor, but lack the
ability to be activated by ligand and subsequently produce cAMP, and would provide a
way to determine which receptor is responsible for the cAMP production with some
amount of certainty.
Cell surface assays offered little insight into what may be causing the differences
in EC50 values observed in the cAMP reporter assays. Simultaneous expression of
rtMC5R with rtMC2R indicates a trend toward a signficiant (p = 0.053) drop in surface
expression of rtMC5R (Figure 10). Additionally, measurement of rtMC2R expression
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was not significantly different than when rtMC2R was expressed individually (Figure
11). Taken together, these data from cells co-expression rtMC5R with rtMC2R give the
impression that rtMC5R can be slightly inhibited by rtMC2R, while rtMC2R may be
enhanced by the presence of rtMC5R. Further functional characterization of the
relationship between these two receptors will serve to clarify this matter.

Rainbow Trout MC5R expression in CHO cells: co-expression with rtMC2R and
zfMRAP1
The immunofluorescence analysis indicated that co-transfection of all three
cDNA constructs resulted in what appeared to be colocalization of rtMC5R with both
MC2R (Figure 6C) and MRAP1 (Figure 6F). Again, these results indicate the possible
interaction of rtMC5R with MC2R as well as MRAP1. Further imaging studies,
including FRET techniques similar to those performed by Pisterzi et al. (2010) in which
each protein would be tagged with a different fluorescent protein, could provide more
support for interactive behavior of rtMC5R with MRAP1. In addition, simultaneous
staining for all three proteins performed on cells that were transfected with rtMC5R,
rtMC2R and zfMRAP1 would provide ideal evidence for potential colocalization and
interaction.
Cyclic AMP reporter assays showed that the presence of all three proteins resulted
in a significant decrease in EC50 values when cells were stimulated with NDP-α-MSH, as
well as a drop in total saturation (Figure 8A). Additionally, identically transfected cells
stimulated with ACTH(1-24) showed a right shift in EC50 and a drop in total saturation,
though neither were significant relative to cells transfected with only rtMC2R and
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zfMRAP1 (Figure 9). The seeming loss of function of rtMC5R in this case is concurrent
with the initial hypothesis that MRAP1 would interfere with the functionality of the
receptor. Furthermore, this change in rtMC5R function could be indicative of a
regulatory mechanism as predicted. As stated previously, the activity of cells stimulated
with ACTH(1-24) cannot be accurately interpreted due to the potential for dual activation
of rtMC5R and rtMC2R.
The decrease in total activation of rtMC5R in cells transfected with all three
cDNA constructs and stimulated with NDP-α-MSH coincides with a significant reduction
in detectable expression of rtMC5R at the plasma membrane. These results strongly
suggest a mechanism for the decrease of the trafficking of rtMC5R to the plasma
membrane. As stated, such a mechanism could prevent HPA/I axis activation during
times of HPC/M activity. Conversely, triple transfection was the only condition which
resulted in a significant increase in detectable rtMC2R at the cell surface.

Conclusions
It has been shown that MRAP1 interacts and coimmunoprecipitates with all
MCRs, including MC5R in mammals indicating the formation of heterodimers at the very
least (Chan et al., 2007). Additionally, larger heteromers have been demonstrated in
other G-protein coupled receptors, including, but not limited to M2 muscarinic receptors
(Pisterzi et al., 2010), D2 Dopamine receptors (Guo et al., 2008; Carriba et al., 2008), α1bAdrenoceptors, cannabinoid CB1, and adenosine A2A receptors (Carriba et al., 2008).
Based on this information, we believe a decrease in surface expression of rtMC5R may
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be due to formation of a large MC5R, MC2R, and MRAP1 heteromer within the cell
which results in prevention of rtMC5R trafficking to the plasma membrane. In addition
this same arrangement of proteins may affect the functionality of rtMC2R at the plasma
membrane, resulting in the increased EC50 and decreased total saturation which are
indicative of slightly decreased functionality.
After completion of this research, a rainbow trout MRAP1 homologue was
discovered. Repetition of assays described in the present study using the rtMRAP1
homologue would provide more conclusive results regarding the authentic interaction of
rtMC5R with MC2R and MRAP1. It is however unlikely that these result are completely
inaccurate due to the use of zfMRAP1, as it has been shown that zfMRAP1 is capable of
interacting with rtMC2R to produce a properly folded, functional receptor that can be
trafficked to the plasma membrane and activated by ACTH (Liang et al., 2011). It is still
possible that the characterization of rtMC5R in this study is not physiologically accurate
due to the use of heterologous MRAP1. As seen in figure 13, there is a great deal of
inconsistency in MRAP1 sequences. The percent homology between zfMRAP1 and
rtMRAP1 may determine the physiological accuracy of these results.
The in vitro studies presented in this thesis reveal three different ways in which
rtMC5R can function in a target cell. When rtMC5R is either expressed alone in a target
cell or co-expressed with MRAP1 there is no major shift in the activation of the receptor.
Rainbow trout MC5R does not require MRAP1 for trafficking to the plasma membrane
or for function activation. While it appears that rtMC5R may form a complex with
MRAP1, this complex did not alter the functional expression of the receptor.
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Figure 13: Alignment of MRAP1 and MRAP2 amino acid sequences. The MRAP1
amino acid sequences for Homo sapiens (Hs), Macaca mulatta (Ma), Microcebes murinus
(Mi), Rattus norvegicus (Rn), Mus musculus (Mm), Gallus gallus (Gg), Oreochromis
niloticus (On), Takifugu rubriipes (Tr), and Danio rerio (Dr) were aligned with the
MRAP2 amino acid sequences from Homo sapiens (Hs), Macaca mulatta (Ma), Gallus
gallus (Gg), Anolis carolinensis (Ac), Xenopus tropicalis (Xt), Takifugu rubriipes (Tr),
Danio rerio (Dr), and Callorhinchus milii (Cm). Shaded in gray are amino acid positions
which display 70% or greater primary sequence identity in both MRAP paralogs. Shaded
in yellow are amino acid positions in which 66% or greater primary sequence identity is
shared in MRAP1 orthologs. In pink are positions in which amino acids share 80% or
better primary sequence identity in mammalian MRAP1 orthologs only. Positions in
which amino acids share 75% or greater primary sequence identity in only MRAP2
orthologs are shaded in green. The N-linked glycosylation site is indicated by an asterisk
(*). The residues 18LDYI21 , which ensure functional activation of MC2R are underlined.
Figure 13 from Liang et al., 2011.
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The co-expression of rtMC5R and rtMC2R, a situation that could occur in some
target cells, appears to result in the formation of heterodimers. However, at present it is
not clear if this is a major or minor event. It did appear that the sensitivity of rtMC5R
under these conditions had decreased, but this shift in EC50 value was not significant.
Hence, it appears that in target cells expressing both receptors the presence of rtMC2R
did not decrease functional activation. In addition, based on the immunofluorescence
staining experiments it appears that at least some rtMC2R is expressed on the plasma
membrane. Whether the rtMC2R on the plasma membrane can be functionally activitated
is not clear. Additional experiments using mutated forms of rtMC5R which lack the
ability to be functionally activated, but not the ability to properly traffic to the plasma
membrane would be required to resolve this issue.
Of the three in vitro conditions, the co-expression of rtMC5R, rtMC2R, and
zfMRAP1 most closely approximated the distribution of melanocortin receptors and
MRAP in interrenal cells. Under these conditions, it appears that the two receptors and
MRAP1 are forming a multimeric complex. In addition, under these conditions, the
functional activation of rtMC5R was significantly impaired because of the presence of
MRAP1. Hence, it would be reasonable to predict that, in the rainbow trout interrenal
cell, the presence of MC2R, MC5R, and MRAP1, the role of rtMC5R is probably not
significant on the surface. As a result activation by α-MSH may not be an issue. If this
conclusion is correct we predict that on the plasma membrane of interrenal cells there is a
population of MC2R/MRAP1 complexes for functional activation of target cell by ACTH
(i.e., HPA/I axis) and a diminished population of either MC5R, or MC5R/MC2R
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heterodimers on the surface of these cells. Future experiments that quantify the
proportion of these various receptor/accessory protein complexes are required to confirm
this hypothesis.
To summarize, this research demonstrated that rtMC5R can be successfully
expressed and functionally activated in CHO cells, and, similar to mammals, α-MSH is
the preferred ligand for rtMC5R (Cone, 2006). The presence of MRAP1 does not seem
to inhibit the expression or function of rtMC5R, rather it appears that it may increase
expression and total activation levels. In contrast, the presence of MRAP1 in conjunction
with MC2R reduces expression and total activation levels of rtMC5R. The cause of these
contrasting effects should be a direction of future study, in addition to repeating the
characterization of rtMC5R with the use of rtMRAP1 to ensure the accuracy of these
findings. The interaction of rtMC5R with MRAP1 and MC2R is one that is complicated,
and ultimately needs a great deal more research to fully characterize.
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